The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Utility of FDG-PET for Investigating Unexplained Plasma CEA Elevation in Patients With Colorectal Cancer
Open accessAbstract
OBJECTIVE: To assess the potential role of positron emission tomography (PET) with 2-[18F]fluoro-2-deoxy-D-glucose (FDG) in patients with unexplained rising carcinoembryonic antigen (CEA) levels after the treatment of colorectal cancer. BACKGROUND: A rising CEA level after the resection of colorectal cancer is an early indicator of tumor recurrence. However, conventional imaging techniques have limited sensitivity for detecting recurrent disease in such patients. Especially after surgical intervention, FDG-PET is rapidly gaining an important role in establishing the extent of disease in the oncology patient. METHODS: Twenty-two patients with abnormal CEA levels and normal results of conventional methods of tumor detection were studied with FDG-PET. The PET results were compared with pathologic findings (n = 9) and long-term radiologic and clinical follow-up (n = 13). RESULTS: FDG-PET was abnormal in 17 of 22 patients. Tissue sampling was available in 7 of these 17 patients; all of these had recurrent disease. Definitive curative surgical intervention was performed in four patients. Subsequent dedicated imaging findings and clinical course confirmed the presence of extensive disease in 8 of the remaining 10 patients; the PET results in the other 2 patients were considered falsely positive. FDG-PET was negative in 5 of 22 patients. No disease was found by tissue sampling (n = 2) and clinical follow-up (n = 3). Overall, the positive-predictive value for PET was 89%, (15 of 17) and the negative-predictive value was 100% (5 of 5). CONCLUSIONS: When conventional examinations are normal, FDG-PET is a valuable imaging tool in patients who have a rising CEA level after colorectal surgery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The applications of PET in clinical oncology.
Strauss, L. G., & Conti, P. S. (1991) · PubMed · Cited by 844
Moertel, C. G. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510080047030 · Cited by 449
Follow-up after curative surgery for colorectal carcinoma: Randomized comparison with no follow-up
Ohlsson, B., Breland, U., Ekberg, H., Graffner, H., & Tranberg, K.-G. (1995) · Diseases of the Colon & Rectum · doi:10.1007/bf02054122 · Cited by 308
Recurrence of colorectal tumors: PET evaluation.
Strauss, L. G., Clorius, J. H., Schlag, P., Lehner, B., Kimmig, B., Engenhart, R., Marin-Grez, M., Helus, F., Oberdorfer, F., & Schmidlin, P. (1989) · Radiology · doi:10.1148/radiology.170.2.2783494 · Cited by 268
PET and [18F]-FDG in oncology: A clinical update
Conti, P. S., Lilien, D. L., Hawley, K., Keppler, J., Grafton, S. T., & Bading, J. R. (1996) · Nuclear Medicine and Biology · doi:10.1016/0969-8051(96)00074-1 · Cited by 259
Haberkorn, U., Strauss, L. G., Dimitrakopoulou, A., Engenhart, R., Oberdorfer, F., Ostertag, H. J., Romahn, J., & KAICK, G. V. (1991) · PubMed · Cited by 241
Schiepers, C., Penninckx, F., De Vadder, N., Merckx, E., Mortelmans, L., Bormans, G., Marchal, G., Filez, L., & Aerts, R. (1995) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/s0748-7983(95)97046-0 · Cited by 235
Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver
Vitola, J. V., Delbeke, D., Sandler, M. P., Campbell, M. G., Powers, T. A., Wright, J. K., Chapman, W. C., & Pinson, C. W. (1996) · The American Journal of Surgery · doi:10.1016/s0002-9610(99)80067-1 · Cited by 228
Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose.
Patz, E. F., Lowe, V. J., Hoffman, J. M., Paine, S., Harris, L. K., & Goodman, P. C. (1994) · Radiology · doi:10.1148/radiology.191.2.8153309 · Cited by 202
Beets, G., Penninckx, F., Schiepers, C., Filez, L., Mortelmans, L., Kerremans, R., Aerts, R., & De Rao, M. (1994) · Journal of British Surgery · doi:10.1002/bjs.1800811136 · Cited by 181
Cited by
(2001) · PubMed · Cited by 943
Bar-Shalom, R., Valdivia, A. Y., & Blaufox, M. D. (2000) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2000.7439 · Cited by 340
Wiering, B., Krabbe, P. F. M., Jager, G. J., Oyen, W. J. G., & Ruers, T. J. M. (2005) · Cancer · doi:10.1002/cncr.21569 · Cited by 256
PET and PET-CT for evaluation of colorectal carcinoma
Delbeke, D., & Martin, W. H. (2004) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2004.03.006 · Cited by 110
Metadata
- Authors
- Flanagan, F. L., Dehdashti, F., Ogunbiyi, O. A., Kodner, I. J., & Siegel, B. A.
- Venue
- Annals of Surgery
- Published
- 1998-03
- Volume
- 227
- Issue
- 3
- Pages
- 319-323
- ISSN
- 0003-4932 (ISSN-L)
- OpenAlex
- W1965964596
- Cited by
- 253
- References
- 15
- FWCI
- 17.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Utility of FDG-PET for Investigating Unexplained Plasma CEA Elevation in Patients With Colorectal Cancer. https://app.cochat.ai/papers/10.1097/00000658-199803000-00001
- The paper
- Flanagan, F. L., Dehdashti, F., Ogunbiyi, O. A., Kodner, I. J., & Siegel, B. A. (1998). Utility of FDG-PET for Investigating Unexplained Plasma CEA Elevation in Patients With Colorectal Cancer. Annals of Surgery. https://doi.org/10.1097/00000658-199803000-00001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
